PREMIER VALUE MERTHIOALATE- benzalkonium chloride liquid 
Chain Drug Consortium

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Premier Value Merthiolate

Premier Value Merthiolate

Drug Facts

Active Ingredient

Benzalkonium Chloride 0.13%

Purpose

Antiseptic

Indications

First aid antiseptic to help skin infection in minor: cuts, scrapes, burns, insect bites.

Warnings

For external use only.

Ask a doctor before use if you have

Deep or puncture wounds

Animal bites

Serious burns

When using this product do not

Get into the eyes

Apply over large areas of the body

Apply over raw surfaces or blistered areas

Use longer than one week unless directed by doctor.

Stop use and ask a doctor if

Redness, swelling or pain persists or increases.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center immediately. Soap will deactivate the effects of this product.

Directions

Inactive Ingredient

Acetone, FD&C Red No 4. Purified water.

Label

image description

PREMIER VALUE MERTHIOALATE 
benzalkonium chloride liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-437
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) BENZALKONIUM CHLORIDE1.3 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ACETONE (UNII: 1364PS73AF)  
FD&C RED NO. 4 (UNII: X3W0AM1JLX)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-437-0059 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product10/26/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart333A10/26/2017
Labeler - Chain Drug Consortium (101668460)
Registrant - Humco Holding Group, Inc. (825672884)
Establishment
NameAddressID/FEIBusiness Operations
Humco Holding Group, Inc.825672884manufacture(68016-437) , analysis(68016-437) , pack(68016-437) , label(68016-437)

Revised: 12/2017
Document Id: 603bdac0-b9d6-15aa-e053-2991aa0a972b
Set id: 40edb2ca-a6c6-4199-a32d-4b4e6b1d063c
Version: 2
Effective Time: 20171213
 
Chain Drug Consortium